Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1Inflammatory Breast Neoplasms 1Breast Neoplasms 1

Interventions

poly ICLC 1Magnetic Resonance Spectroscopy 1Flow Cytometry 1Enzyme-Linked Immunosorbent Assay 189Zr-bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Inflammatory Breast Neoplasms × Flow Cytometry × Clear all
NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡